| Authors: |
Lorenz DR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Mukerji SS; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Misra V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Uno H; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gelman BB; Department of Pathology, University of Texas Medical Branch, Galveston, TX., Moore DJ; Department of Psychiatry, University of California San Diego, La Jolla, CA., Singer EJ; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA; and., Morgello S; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY., Gabuzda D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. |
